Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06688903

App-based Diabetes Management and Community-based Interventions

EMPOWERing Patients With Chronic Diseases Through Smartphone App, Health Coaching and Community-based Intervention

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
150 (estimated)
Sponsor
Singapore General Hospital · Academic / Other
Sex
All
Age
21 Years
Healthy volunteers
Not accepted

Summary

Community-based health coaching interventions play a vital role in complementing the traditional chronic disease management model for type 2 diabetes patients. Compared to conventional approaches that often focus on periodic clinical visits, community-based coaching could provide continuous, personalised support within patients in everyday environments. Health coaches work directly with patients to set realistic goals, develop individualised action plans, and provide ongoing motivation and accountability. This personalised attention helps to improve self-management skills, such as medication adherence, dietary choices, and physical activity, which are crucial for chronic disease management and preventing complications. Our mobile health app, EMPOWER+ has multiple logging features, gamified elements to help users set goals and provide rewards, educational resources, and personalised nudges generated based on real users; inputs and predictive modeling. It has demonstrated some preliminary effectiveness and acceptability within the clinical settings. This trial aims to assess its effectiveness, adoption, and sustainability in the less-controlled community settings, preparing for its large implementation in the future.

Conditions

Interventions

TypeNameDescription
BEHAVIORALApp-based diabetes management and community-based health coachingAll participants will use the EMPOWER+ app and a Fitbit wearable. They will also received community-based health coaching and/or other prescribed structured programmes.

Timeline

Start date
2024-01-06
Primary completion
2025-12-31
Completion
2026-06-30
First posted
2024-11-14
Last updated
2025-02-25

Locations

2 sites across 1 country: Singapore

Source: ClinicalTrials.gov record NCT06688903. Inclusion in this directory is not an endorsement.